An observational study in Computerized Physician Order Entry, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 24 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-07-11.
Sponsored by National Taiwan University Hospital · Observational
The objective of this prospective study is to build a real-time interactive platform where doctors and pharmacists may communicate and solve patients' drug-related problems (DRP) immediately and document accordingly. This study will also design a computerized physician order entry (CPOE) system utilizing default protocol for chemotherapy order entry.
To err is human. Most errors are caused by problems in the system. Punishing health personnel cannot prevent the same mistakes. The only solution is a good medication system. CPOE system can prevent prescribing errors. The CPOE system is always the major step in some studies concerning reducing prescribing errors, dispensing errors or administering errors. In this user-friendly and convenient era, improvement in the CPOE system is an immediate need.
National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 568 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
NTUH pharmacists
Exclusion Criteria:
Those who will use the new CPOE system
Behavioral: satisfaction questionnaire
Satisfaction questionnaire
Also known as: questionnaire
the timeliness and efficiency of pharmacist's response in DRPs, the average prescription error rate and the satisfaction questionnaire before and after implementation of the new CPOE system.
Time frame: 2 year
This study is status unknown, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital